- Home
- MYGN vs APLD Comparison
MYGN vs APLD Comparison
Compare MYGN & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- APLD
- Stock Information
- Founded
- MYGN 1991
- APLD 2001
- Country
- MYGN United States
- APLD United States
- Employees
- MYGN N/A
- APLD N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- APLD Investment Bankers/Brokers/Service
- Sector
- MYGN Health Care
- APLD Finance
- Exchange
- MYGN Nasdaq
- APLD Nasdaq
- Market Cap
- MYGN 744.7M
- APLD 1.3B
- IPO Year
- MYGN 1995
- APLD N/A
- Fundamental
- Price
- MYGN $5.00
- APLD $9.98
- Analyst Decision
- MYGN Hold
- APLD Strong Buy
- Analyst Count
- MYGN 15
- APLD 11
- Target Price
- MYGN $15.14
- APLD $12.64
- AVG Volume (30 Days)
- MYGN 1.3M
- APLD 32.1M
- Earning Date
- MYGN 08-05-2025
- APLD 07-30-2025
- Dividend Yield
- MYGN N/A
- APLD N/A
- EPS Growth
- MYGN N/A
- APLD N/A
- EPS
- MYGN N/A
- APLD N/A
- Revenue
- MYGN $831,300,000.00
- APLD $221,192,000.00
- Revenue This Year
- MYGN N/A
- APLD $34.51
- Revenue Next Year
- MYGN $6.68
- APLD $7.42
- P/E Ratio
- MYGN N/A
- APLD N/A
- Revenue Growth
- MYGN 7.38
- APLD 53.70
- 52 Week Low
- MYGN $3.81
- APLD $3.01
- 52 Week High
- MYGN $29.30
- APLD $15.42
- Technical
- Relative Strength Index (RSI)
- MYGN 43.78
- APLD 49.58
- Support Level
- MYGN $4.90
- APLD $9.02
- Resistance Level
- MYGN $5.83
- APLD $9.64
- Average True Range (ATR)
- MYGN 0.29
- APLD 0.63
- MACD
- MYGN -0.02
- APLD -0.20
- Stochastic Oscillator
- MYGN 10.75
- APLD 35.82
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments; Data Center Hosting Business, Cloud Services Business, and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business which operates data centers to provide energized space to crypto mining customers.